GDA-501 | m-entrepreneurship.com

Product Name :
GDA-501

Search keywords :
GDA

drugId :
null

Target Vo:
Unidentified

Target Vo Short Name :
Unidentified

Moa_Name:
Immunologic cytotoxicity

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Gamida Cell Ltd

Active Company_Name :
Gamida Cell Ltd

Active Indication_Name:
Solid tumours

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Semorinemab Neuronal Signaling
Phospho-STAT3(Tyr705) Rabbit mAb MedChemExpress
CDKN2A Antibody: CDKN2A Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 17 kDa, targeting to CDKN2A. It can be used for WB,IP assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts